Using Legal Preparedness to Minimize Liability Barriers to Accessing Pandemic Vaccine and Medical Countermeasures
Bill of Health
OCTOBER 24, 2022
In a public health emergency, pharmaceutical manufacturers’ liability concerns can slow the deployment of urgently needed vaccines and other medical countermeasures (MCMs). Products used during public health emergencies raise unique issues either because of their novelty, scale and type of proposed use, or regulatory pathway.
Let's personalize your content